Massimo Bertinaria

9PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesGene and molecular therapyAgricultural molecular engineering of nucleic acids and proteinsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2026
Beneficial Effects of a Dual Cyclooxygenase Inhibitor-Thromboxane Antagonist in Counteracting High-Fat Diet-Induced Metaflammation.

|Oct 22, 2025
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Federica Blua, Francesca Boccato, Carola Buccellati

|Dec 11, 2022
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein.

Elisabetta Marini, Marco Marino, Giulia Gionfriddo

|Jan 21, 2022
Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study.

Elisabetta Marini, Marta Giorgis, Marta Leporati

|Nov 27, 2021
Inflammasome Inhibitors.

Massimo Bertinaria

|Jul 02, 2021
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor.

Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto

Pageof 2

Frequent Collaborators

5 joint publications

Marta Giorgis

4 joint publications

Elisabetta Marini

3 joint publications

Federica Blua

3 joint publications

Barbara Rolando